利用结构预测Polo-Like激酶4用于药物重定位的结构预测
Harshita Kasera1, Priyanka Singh1
1Department of Bioscience & Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, India.
Cytoskeleton (Hoboken, N.J.)
|March 20, 2025
概括
研究人员将alectinib确定为一种潜在的药物,通过专注于其独特的polo-box域 (PBD) 来准Polo-like kinase 4 (PLK4). 这为癌症疗法提供了更具体的方法,通过重新利用现有的化学支架来治疗癌症.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 癌症生物学 癌症生物学
背景情况:
- 波罗样酶4 (PLK4) 是一个关键的中心细胞调节剂,在各种癌症中表达异常.
- 目前的PLK4抑制剂向激酶域,由于与其他激酶的结构相似性,有可能产生非向效应.
- 针对PLK4的独特的C终端波罗盒域 (PBD) 提供了一种增强药物特异性的策略.
研究的目的:
- 预测人类PLK4.4的全长结构.
- 通过虚拟选化学库,寻找针对独特PLK4区域的化合物,特别是PBD.
- 为了确定PLK4驱动癌症的新型治疗支架.
主要方法:
- 利用ab initio和线程方法进行全长的人类PLK4结构预测.
- 对预测的PLK4结构进行了对ChEMBL库的虚拟选.
- 采用FT-IR分析来确认药物向相互作用.
主要成果:
- 成功预测了人类PLK4.4的全长结构.
- 确定了alectinib作为一种针对PLK4.4独特区域的打击化合物.
- 观察到,阿莱克提尼布会影响与PLK4水平相关的中心细胞数.
- FT-IR证实了阿莱克提尼布与PLK4 PBD的相互作用.
结论:
- 阿列克提尼布显示出作为治疗剂的潜力,向PLK4.4独特的PBD.
- 这项研究确定了一种化学支架,可以用于开发特定的PLK4抑制剂.
- 这些发现通过利用PLK4独特的结构特征,为更有针对性的癌症治疗铺平了道路.
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Structure-Activity Relationships and Drug Design
471
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
471
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


